Timothy J. Ley

Affiliations: 
Biology & Biomedical Sciences (Molecular Cell Biology) Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular Biology, Cell Biology, Genetics
Google:
"Timothy Ley"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gruszczynska A, Maiti A, Miller CA, et al. (2024) Molecular responses in decitabine- and decitabine/venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes. Haematologica
Li Y, Abel HJ, Cai M, et al. (2024) Rapid and accurate remethylation of DNA in deficient hematopoietic cells with restoration of DNMT3A activity. Science Advances. 10: eadk8598
Abel HJ, Oetjen KA, Miller CA, et al. (2023) Genomic landscape of TP53-mutated myeloid malignancies. Blood Advances
Abel HJ, Oetjen KA, Miller CA, et al. (2023) Genomic landscape of -mutated myeloid malignancies. Medrxiv : the Preprint Server For Health Sciences
Kramer MH, Zhang Q, Sprung R, et al. (2022) Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia. Blood
Petti AA, Williams SR, Miller CA, et al. (2022) Author Correction: A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nature Communications. 13: 4216
Menssen AJ, Khanna A, Miller CA, et al. (2022) Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression. Blood Cancer Discovery. OF1-OF16
Li S, Yao JC, Oetjen KA, et al. (2022) IL-1b expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function. Blood
Upadhyay P, Beales J, Shah NM, et al. (2022) Recurrent Transcriptional Responses in AML and MDS patients Treated with Decitabine. Experimental Hematology
Smith AM, Verdoni AM, Abel HJ, et al. (2022) Somatic inactivation leads to slow, canonical DNA methylation loss in murine hematopoietic cells. Iscience. 25: 104004
See more...